Oncology: International Journal of Cancer Research and Treatment
Fecha de publicación: March 2018
Autores: Lee S.J., Lee J., Kim W.W., Jung J.H., Park H.Y., Park J.-Y., Chae Y.S.
Background: A differential diagnostic role for plasma Del-1 was proposed for early breast cancer (EBC) in our previous study. We examined tumoral Del-1 expression and analyzed its prognostic impact among patients with EBC.